A Conversation with PATH’s Malaria Vaccine Initiative

In 2021, the first genetically modified mosquitoes were released in the United States as part of field a testing experiment a method for suppressing populations of wild Aedes aegypti mosquitoes, which can carry diseases such as Zika, dengue, chikungunya, and yellow fever. News of this work spread rapidly in the malaria prevention community as a potential technology that could inform the future of malaria control. 

This highly anticipated event will provide an overview of Oxitec’s work, particularly the Oxitec Mosquito Project. We will share information on the challenges this project faced (including regulatory) and the future of genetically modifying mosquitos for disease prevention. 

Panelists for this event include:

-Rajeev Vaidyanathan, Director of U.S. Programs, Oxitec

-Meredith Fensom, Head of Global Public Affairs, Oxitec

-Moderator: Kaj Pedersen, Chief Technology Officer at AstrumU

Broadcast link:

The webinar will be broadcasted on November 4, 2021 – 9:00am PDT. Here is the registration link for this event: https://www.malariapartnersinternational.org/webinar-registration/